- Min.Order :1 Kilogram
- Purity: 98% purity
- Payment Terms : L/C,T/T,Other
Keywords
Wholesale 165800-03-3 used for selective proteasome inhibitor Sale 165800-03-3 is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-s 165800-03-3 China suppliers
Quick Details
- Appearance:light yellow solid
- Application:179324-69-7 1>Bortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein
- PackAge:1g;5g;10g;25g;50g;100g;500g;1KG;5KG,25kg,50kg or as customers request
- ProductionCapacity:20|Kilogram|Month
- Storage:Room temperature with sealed well
- Transportation:BY SEA /BY AIR /BY COURIER
Superiority:
1. ISO 9001 approved, GMP producing standard,Proffesional QA system, our quality is guaranteed.
2. Facotory direct sale, most comptive price ensured;
3. Audited Supplier on lookchem, No trick, No Scam!
4. Enough stock can make sure safe delivery.
5. Complete before and after sale service, welcome your questions and glad to help.
Details:
PRODUCT INFORMATION :
| Linezolid Basic information |
| Product Name: | Linezolid |
| Synonyms: | LINEZOLID;LINEZOLIDE;ACETAMIDE, N-[[(5S)-3-[3-FLUORO-4-(4-MORPHOLINYL)PHENYL]-2-OXO-5-OXAZOLIDINYL]METHYL]-;(s)-n-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI);Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-;PNU 100766;U 100766 |
| CAS: | 165800-03-3 |
| MF: | C16H20FN3O4 |
| MW: | 337.35 |
| EINECS: | |
| Product Categories: | Antibacterial;Aromatics Compounds;Aromatices;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;API;Pfizer compounds;TYGACIL |
| Mol File: | 165800-03-3.mol |
|
|
|
| Linezolid Chemical Properties |
| mp | 176-1780C |
| storage temp. | Store at RT |
| CAS DataBase Reference | 165800-03-3(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36 |
| HS Code | 29419000 |
| Hazardous Substances Data | 165800-03-3(Hazardous Substances Data) |
| MSDS Information |
| Provider | Language |
|---|---|
| Linezolid | English |
| Linezolid Usage And Synthesis |
| Outline | Linezolid (U- 100766, PNU-100766) developed and produced by the US Pharmacia & Upiohn company (which has been acquired by Pfizer) ,is a new type of azole oxazolidinone class of synthetic antibacterial drugs, the FDA on April 18, 2000 approved the drug to market. This product is the first drug in American in 40 years which is approved for the treatment of methicillin-resistant Staphylococcus aureus infection, September 2007 month in China's listed, it belongs to the Medicare B drugs. |
| Indications |
For the treatment of Gram-positive (G +) bacteria caused infections, including concurrent bacteremia; nosocomial pneumonia; community-acquired pneumonia ( because bacteria are not the same,pneumonia is clinically divided into hospital-acquired pneumonia and community-acquired pneumonia) and concomitant bacteremia; it can be applied for the complexity of the skin and skin and soft tissue infections, including osteomyelitis in diabetic foot infections; uncomplicated skin and skin and soft tissue infections; it is also used for the treatment of vancomycin-resistant feces enterococci. The above information is edited by the chemicalbook of Tian Ye. |
| Application |
fully synthetic oxazolidinone antibiotics. oxazolidinone antibacterial drugs. anti-inflammatory drug. inhibit bacterial mRNA translation. |
| Chemical Properties | White Solid |
| Usage | Prototype of the oxazolidinone antimicrobials; inhibits bacterial mRNA translation. |
| Usage | antibacterial |
| Biological Activity | Oxazolidinone antibiotic. Inhibits bacterial protein synthesis prior to chain initiation. Displays potent antibacterial activity against a variety of multidrug-resistant gram-positive microbes in vitro and in vivo . |
COMPANY INFORMATION :
HenNan sunlake enterprise corporation is located in Henan Province , The central plain of China , Which enjoys favorable geogeaphical position and convenient transportion, The com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .
Sunlake is a professional manufacturer engaged in producing and selling chemicals,including Organic & inorganic chemicals , pigments & Dyestuffs , Water treatment chemicals , Food & FEED additives and others . these products have been being well exported to europe , southeast Asia , the Middle East , Africa , South America and some other countries and areas.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View